<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03118310</url>
  </required_header>
  <id_info>
    <org_study_id>Dnr 2017/258-31</org_study_id>
    <nct_id>NCT03118310</nct_id>
  </id_info>
  <brief_title>Treatment of NAFLD With Two Different Diets</brief_title>
  <acronym>TREND</acronym>
  <official_title>Treatment of NAFLD With Two Different Diets</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of popular diets on liver-related health is unclear. In this randomized,
      controlled trial, patients with NAFLD will be randomized to one of two popular diets or a
      placebo diet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will include patients with MRI-verified NAFLD, with no concurrent liver diseases.
      Randomization will be done to either a control diet, the 5:2 diet or a low-carb-high-fat
      diet. The subjects will follow the diet for three months, after which a new MRI is performed.
      Main outcomes measure is reduction in liver fat.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 6, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver fat</measure>
    <time_frame>Three months</time_frame>
    <description>MRI-measured liver fat content</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>NAFLD</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5:2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5:2 diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LCHF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>LCHF diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>5:2 diet</intervention_name>
    <description>Dietary intervention according to 5:2 diet during three months.</description>
    <arm_group_label>5:2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>LCHF</intervention_name>
    <description>Dietary intervention according to LCHF diet during three months.</description>
    <arm_group_label>LCHF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Placebo diet</intervention_name>
    <description>Placebo diet: normal dietary advice</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Known NAFLD

        Exclusion Criteria:

          -  Other forms of liver disease

          -  Bolus insulin treatment

          -  Cirrhosis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannes Hagström, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hannes Hagström, MD, PhD</last_name>
    <phone>0046858580000</phone>
    <email>hannes.hagstrom@ki.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Per Stål, MD, ass prof</last_name>
    <phone>0046858580000</phone>
    <email>per.stal@ki.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center for Digestive Diseases, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannes Hagström, MD, PhD</last_name>
      <phone>0046858580000</phone>
      <email>hannes.hagstrom@ki.se</email>
    </contact>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2017</study_first_submitted>
  <study_first_submitted_qc>April 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Hannes Hagström</investigator_full_name>
    <investigator_title>Primary Investigator</investigator_title>
  </responsible_party>
  <keyword>Reduction of liver fat</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

